Idiopathic pulmonary fibrosis (IPF) is the most common interstitial lung disease among middle-aged and elderly adults. Although the cause of IPF is unknown, factors thought to increase an individual's risk of developing IPF include a history of smoking, gastroesophageal reflux disease, environmental exposures, and genetic predispositions. Patients with IPF typically present with fatigue, dry cough, and progressive respiratory distress of more than 6 months. The clinical course of IPF is complicated and the prognosis is poor, with a median survival of 3-5 years from diagnosis. Early diagnosis of IPF and initiation of treatment are essential to improve patient outcomes.
How much do you know about IPF treatment? Test your knowledge with this quick quiz.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Guy W. Soo Hoo, Zab Mosenifar. Fast Five Quiz: Idiopathic Pulmonary Fibrosis Treatment - Medscape - Dec 13, 2022.
Comments